Abstract
Mitral stenosis (MS) is almost invariably the result of long term complication of rheumatic fever. Based upon the nature and severity of MS, patients can be managed with medical treatment, percutaneous transvenous mitral commissurotomy (PTMC) or surgery. PTMC is proven to be simple, effective and safe; it is considered as treatment of choice in the management of MS. In Shahid Gangalal National Heart Centre, PTMC service started in 2001. First PTMC in the centre was done on 14th April 2001. Till June2016, 6023 PTMCs were done in the centre. Multiple studies evaluated the safety and efficacy of PTMC in different groups of patients. These studies clearly demonstrated the safety and effectiveness of PTMC in our centre. This article summarizes the historical development, current status and future perspectives of PTMC procedure at Shahid Gangalal National Heart Centre, a teritary care cardiac centre in Nepal.Nepalese Heart Journal 2016; 13(2): 15-17
Highlights
Acquired Mitral stenosis (MS) is almost invariably the result of long term sequelae of rheumatic fever.[1]
Based upon the nature and severity of MS, patients can be managed with medical therapy, percutaneous transluminal mitral commissurotomy (PTMC) or surgery
PTMC is recommended for symptomatic patients with severe MS (mitral valve area (MVA) ≤1.5 cm2) and favorable valve morphology in the absence of left atrial (LA) thrombus and or moderate-to-severe mitral regurgitation (MR).[12]
Summary
Acquired Mitral stenosis (MS) is almost invariably the result of long term sequelae of rheumatic fever.[1]. In the first study published to evaluate the safety and efficacy of PTMC in SGNHC, Two hundred patients from January 2003 to July 2004 were studied. Mean LA pressure decreased from 21 to 7 mmHg. There was no mortality during the hospital stay or within the first month of the procedure.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
